TD Asset Management
DTIL icon

TD Asset Management’s Precision BioSciences DTIL Stock Holding History

TD Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,156
Closed -$342K – 1534
2021
Q2 		$342K Sell
1,156
-546
-32% -$164K ﹤0.01% 1430
2021
Q1 		$528K Buy
+1,702
New +$596K ﹤0.01% 1387

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

TD Asset Management's DTIL Position: Q3 2021 in Review

TD Asset Management sold out of Precision BioSciences (DTIL) in Q3 2021, closing a stake of 1,156 shares — an estimated $342K sold.

TD Asset Management first reported a position in DTIL in Q1 2021 and held it in 2 quarters. The position peaked at $528K in Q1 2021. 132 funds tracked by Wall St. Rank hold DTIL as of Q3 2021.

  • TD Asset Management reported no remaining Precision BioSciences position as of Q3 2021 after selling out during the quarter.
  • TD Asset Management sold 1,156 Precision BioSciences shares in Q3 2021, an estimated $342K.
  • TD Asset Management first reported a position in Precision BioSciences in Q1 2021 and held it in 2 quarters.
  • TD Asset Management's Precision BioSciences position peaked at $528K in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2021.

Based on TD Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.